The first three genes with the highest GINS2 gene change rate occurred in prostate cancer (5.47% in 494 cases), uterine sarcoma (5.26% in 57 points), and invasive breast carcinoma (2.58% in 1084 cases) (Figure 2(e)). Here, GINS2 is linked to uterine corpus sarcoma.